Category: Life Sciences
Global Life Sciences
-
Avocado Oil
... CAGR of 6.0% over the analysis period 2024-2030. Extra Virgin Oil, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$739.9 Million by the end of the ... Read More
-
Baobab Powder
... CAGR of 5.0% over the analysis period 2024-2030. Organic Baobab Powder, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$10.4 Billion by the end of the ... Read More
-
Betaine
... 4.6% over the analysis period 2024-2030. Synthetic Betaine, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth ... Read More
-
Biotech Seeds
... CAGR of 8.4% over the analysis period 2024-2030. Cotton Crops, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$48.6 Billion by the end of the analysis ... Read More
-
Blood Culture Tests
... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Breast Implants
... CAGR of 6.0% over the analysis period 2024-2030. Silicone Implants, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Breast Imaging Technologies
... at a CAGR of 5.2% over the analysis period 2024-2030. Ionizing Technologies, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Periodontal Dental Services
... at a CAGR of 7.5% over the analysis period 2024-2030. Non-Surgical Services, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$17.3 Billion by the end of ... Read More
-
Rotary Pumps
... CAGR of 5.3% over the analysis period 2024-2030. Gear Pumps, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$3.7 Billion by the end of the analysis ... Read More
-
Spinal Trauma Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Internal Fixation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$4.9 Billion by the end ... Read More
-
Surgical Blades
... CAGR of 3.8% over the analysis period 2024-2030. Sterile Surgical Blades, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$189.4 Million by the end of the ... Read More
-
Surgical Drains / Wound Drainage
... Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Surgical Drains / Wound Drainage Accessories, one of the segments analyzed in the report, is expected to record a 3.6% CAGR ... Read More
-
Surgical Microscopes
... CAGR of 7.8% over the analysis period 2024-2030. Hospital End-Use, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$927.5 Million by the end of the analysis ... Read More
-
Surgical Imaging Technologies
... at a CAGR of 2.7% over the analysis period 2024-2030. Image Intensifier C-arms Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$3.4 Billion by the ... Read More
-
Surgical Sutures
... CAGR of 5.4% over the analysis period 2024-2030. Suture Thread, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the end of the analysis ... Read More
-
Systemic Lupus Erythematosus (Sle) Drugs
... Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$68.0 Million While China is Forecast to Grow at 6.1% CAGR The Systemic Lupus Erythematosus ... Read More
-
Peristaltic Pumps
... CAGR of 3.6% over the analysis period 2024-2030. Hose Pumps, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$721.5 Million by the end of the analysis ... Read More
-
PET-CT Scanners
... CAGR of 5.0% over the analysis period 2024-2030. Stationary PET-CT Scanners, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Pharmaceutical Contract Packaging
... at a CAGR of 5.8% over the analysis period 2024-2030. Primary Packaging, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.7 Billion by the end of ... Read More
-
Point-of-Care/Rapid Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Positive Material Identification
... at a CAGR of 6.5% over the analysis period 2024-2030. Positive Material Identification Equipment, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.2 Billion by the ... Read More
-
Protein Supplements
... CAGR of 6.3% over the analysis period 2024-2030. Animal-Based Supplements, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$22.5 Billion by the end of the analysis ... Read More
-
Radiation Dose Management
... at a CAGR of 13.7% over the analysis period 2024-2030. Radiation Dose Management Solutions, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$479.6 Million by the ... Read More
Research Assistance
